Herantis Pharma: Invitation to 2H & FY 2022 report webinar on March 2, 2023
Herantis Pharma Plc, Company release, 21 February 2023 at 1:00 p.m. EET Herantis Pharma Plc (“Herantis”), a company developing disease-modifying therapies for Parkinson’s disease, announced today that it will release 2H & FY 2022 Report on Thursday, March 2, 2023, at 08:00 EET/ 07:00 CET. Members of the Herantis’ Management team will hold a live webinar to provide more details on the 2H & FY 2022 Report with a live Q&A session (in English) at 10:00 EET / 9:00 CET on the same day. Please join the webinar a few minutes in advance. Register for Herantis Pharma’s 2H & FY 2022 Report